Overview
Jason E. Lang
Current Duke Appointments & Affiliations
Associate Professor of Pediatrics
·
2024 - Present
Pediatrics, Pulmonary and Sleep Medicine,
Pediatrics
Member in the Duke Clinical Research Institute
·
2021 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Mechanistic study of inspiratory training in childhood Asthma: Rationale and methods of a pediatric clinical trial.
Journal article Contemp Clin Trials Commun · June 2026 Asthma is a common pediatric disease of the airways. Obesity among children increases the risk of asthma and is associated with a unique non-allergic asthma phenotype that is highly symptomatic and often unresponsive to conventional drugs. However, the mec ... Full text Link to item CitePopulation Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.
Journal article J Clin Pharmacol · April 2026 Furosemide is the most commonly used diuretic in preterm infants despite an incompletely understood relationship between dosing, exposure, and safety within this population. The goals of this study were to characterize furosemide population pharmacokinetic ... Full text Link to item CitePharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM).
Journal article Contemp Clin Trials Commun · February 2026 Bronchopulmonary dysplasia (BPD) is an inflammatory disease stemming from premature birth and iatrogenic lung injury. BPD is relatively common and frequently fatal; despite this, there are no FDA-approved therapies. Montelukast is increasingly used to trea ... Full text Link to item CiteRecent Grants
Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST). A cluster randomized trial of point-of-care hepatitis C testing and treatment among key populations
ResearchMedical Monitor · Awarded by National Institute of Allergy and Infectious Diseases · 2025 - 20301/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)
ResearchMedical Monitor · Awarded by National Institutes of Health · 2025 - 2029NICHD Pediatric and Maternal Resource Center: Bridging Pharmacology and the Real World
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2028View All Grants
Education
University of Florida ·
2012
M.P.H.
University of Vermont, College of Medicine ·
1998
M.D.